Hypokalemia associated with mifepristone use in the treatment of Cushing’s syndrome

SUMMARY: Mifepristone is a promising option for the management of hypercortisolism associated with hyperglycemia. However, its use may result in serious electrolyte imbalances, especially during dose escalation. In our patient with adrenocorticotropic hormone-independent macro-nodular adrenal hyperp...

Descripción completa

Detalles Bibliográficos
Autores principales: Sai, Katta, Lal, Amos, Lakshmi Maradana, Jhansi, Velamala, Pruthvi Raj, Nitin, Trivedi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2019
Materias:
Unusual Effects of Medical Treatment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6865352/
https://www.ncbi.nlm.nih.gov/pubmed/31743097
http://dx.doi.org/10.1530/EDM-19-0064

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6865352/
https://www.ncbi.nlm.nih.gov/pubmed/31743097
http://dx.doi.org/10.1530/EDM-19-0064

Ejemplares similares